The effect of spiroarsoranes on Trypanosoma brucei brucei and T. b. rhodesiense

Parasitology Research

Volumn 82, Issue 5, 1996, Pages 477-480

  Loiseau, P M ^a   Jennings, F W ^b   Lubert, P ^c   Wolf, J G ^c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; SPIROARSORANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TRYPANOSOMA BRUCEI; TRYPANOSOMA RHODESIENSE; TRYPANOSOMIASIS;

ANIMALS; ARSENICALS; CENTRAL NERVOUS SYSTEM; FEMALE; MOLECULAR STRUCTURE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 0029999785     PISSN: 00443255     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004360050148     Document Type: Article

References (17)

1. Dreyfuss G, Loiseau P, Wolf JG, Bories C, Gayral P, Nicolas JA (1988) Une nouvelle série d'organoarséniés antiparasitaires: les spiroarsoranes. Activité trypanocide expérimentale. Bull Soc Pathol Exot Filiales 81: 561-570
2. Jennings FW (1988) The potentiation of arsenicals with difluoromethylornithine (DFMO); experimental studies in murine trypanosomiasis. Bull Soc Pathol Exot Filiales 81: 595-607
3. Jennings FW (1992) Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system. Trans R Soc Trop Med Hyg 86: 257-258
4. Jennings FW, Atouguia JM, Murray M (1994) Topical chemotherapy of experimental trypanosomiasis. Proceedings, 3rd congress on cost acrival antiparasitic chemotherapy, June 27-28, Basel
5. Jennings FW, Gray GD (1983) Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Contr Microbiol Immunol 7: 147-154
6. Kaminsky R, Gumm ID, Zweygarth E, Chuma F (1990) A drug incubation infectivity test (DUT) for assessing resistance in trypanosomes. Vet Parasitol 34: 335-343
7. Leo A, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem Rev 71: 525-616
8. Loiseau PM, Madaule Y, Wolf JG, Bories C, Gayral P (1987) Une nouvelle classe de composés antiparasitaires: les spiroarsoranes. Evaluation in vitro sur la filaire Molinema dessetae. Eur J Med Chem 22: 439-443
9. Loiseau PM, Bories C, Gayral P, Wolf JG (1988) Trypanocidal activity of a new series of arsenical compounds, the spiroarsoranes. Farmaco 7-8: 657-663
10. Loiseau PM, Wolf JG, Gayral P (1993) Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei. Trop Med Parasitol 44: 32-36
11. Loiseau PM, Bories C, Trabelsi M, Gayral P, Wolf JG (1994) Contribution of N,N'-dialkylbenzamide groups to trypanocidal properties of Spiroarsoranes. Parasitol Res 80: 708-710
12. Loiseau PM, Trabelsi M, Gayral P, Wolf JG (1995) The incorporation of N,N'-bis(2,3-dihydroxybenzoyl)-1,6 diazahexane or octane as the ligands of spiroarsoranes: their effect on trypanocidal activity. Acta Trop (Basel) 59: 237-241
13. Rekik L, Coulais Y, Cailland C, Campistron G, Wolf JG, Houin G (1986) Spiroarsoranes, a new class of antiparasitical compounds: quantitative analysis by high-performance liquid chromatography. J Chromatog Biomed Appl 377: 405-409
14. Rekik L, Coulais Y, Rochas MA, Campistron G, Wolf JG, Houin G (1989) Pharmacokinetics of two spiroarsoranes administered intravenously or orally to rabbits. J Pharm Sci 78: 203-205
15. WHO (1986) Epidemiology and control of African trypanosomiasis. WHO Tech Rep Ser 739:118-121
16. Wolf JG, Madaule Y, Loiseau PM, Gayral P (1984) Arsenicaux antiparasitaires. Nouveaux dérivés de l'arsenic, leur préparation et leur application notamment comme médicaments antiparasitaires. French Patent FR 84-16784, 2 November. French Patent Office, Paris
17. Yarlett N, Goldberg B, Nathan HC, Garofalo J, Bacchi CJ (1991) Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals. Exp Parasitol 72: 205-215